EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of Monocyte Subsets in the Bone Marrow of Patients With Acute Myeloid Leukemia and Its Clinical Significance

Liangjun Zhang iD, Man Chen iD, Huixiu Zhong iD, Jingyuan Huang iD, Ziling Xu iD, Minggang Yin iD, Yi Li iD, Chengjian Cao iD

Journal of Immunology Research · 2025

DOI: 10.1155/jimr/2554167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Liangjun Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zigong First People's Hospital, Zigong City, Sichuan Province, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Monocytes, Bone Marrow, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The bone marrow (BM) microenvironment plays a crucial role in acute myeloid leukemia (AML), but the distribution and clinical significance of monocyte subsets within this compartment remain poorly characterized. This study aimed to investigate the composition of BM monocyte subpopulations and their relationship with systemic immunity and clinical outcomes in AML patients.

Methods

We collected BM samples from 98 AML patients (including 23 newly diagnosed, 28 nonremission, and 47 complete remission [CR] cases) and 23 healthy controls (HCs). Using flow cytometry, we analyzed monocyte subsets (classical, intermediate, nonclassical) and monocytic myeloid‐derived suppressor cells (m‐MDSCs) in BM, along with T lymphocyte subsets in peripheral blood. Survival analysis was performed with 1‐year follow‐up data.

Results

Both the proportion of intermediate monocytes and m‐MDSCs among total monocytes were significantly elevated in newly diagnosed AML patients compared to those in HCs ( p = 0.019 and p = 0.003, respectively) and CR ( p = 0.003 and p = 0.037, respectively). This elevation was followed by a gradual decrease from diagnosis to remission. Multivariate Cox regression identified intermediate monocyte percentage as an independent prognostic factor (HR = 4.170, p = 0.034). Kaplan–Meier analysis confirmed that higher intermediate monocyte levels predicted shorter overall survival (OS) ( p = 0.031) and leukemia‐free survival (LFS) ( p = 0.028). Importantly, negative correlations were observed between BM blasts and peripheral blood T‐cell percentage ( r = −0.467, p = 0.005) and CD8 + T cells ( r = −0.504, p = 0.002), and between intermediate monocytes among total monocytes and total T‐cell percentage ( r = −0.475, p = 0.004).

Conclusions

BM monocyte subsets, particularly intermediate monocytes, serve as significant indicators of disease progression and survival in AML. Their correlation with peripheral T‐cell immunity suggests their potential role in modulating antileukemic immune responses. These findings highlight the prognostic value of BM monocyte profiling and provide insights for developing novel immunotherapeutic strategies in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMonocytesBone MarrowMyeloid-Derived Suppressor CellsHumansFemaleMaleMiddle AgedAdultAgedPrognosisYoung AdultT-Lymphocyte SubsetsImmunophenotypingTumor MicroenvironmentAdolescentAged, 80 and overKaplan-Meier EstimateFlow CytometryClinical Relevance

Stichwörter der Autor:innen

acute myeloid leukemiaclassical monocytesintermediate monocytesmonocyte subsetsprognosis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zigong First People's Hospital, Zigong City, Sichuan Province, China.
  • Department of Laboratory Medicine, HeBei Yanda Lu Daopei Hospital, Yanda City, HeBei Province, China.
  • Department of Laboratory Medicine, Zigong Fourth People's Hospital, Zigong City, Sichuan Province, China, zg120.cn.
  • Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China, scu.edu.cn.

ORCID-Profile: Liangjun Zhang, Man Chen, Huixiu Zhong, Jingyuan Huang, Ziling Xu, Minggang Yin, Yi Li, Chengjian Cao

Zitieren

APA

Zhang, L., Chen, M., Zhong, H., Huang, J., Xu, Z., Yin, M., Li, Y., & Cao, C. (2025). Detection of Monocyte Subsets in the Bone Marrow of Patients With Acute Myeloid Leukemia and Its Clinical Significance. Journal of Immunology Research. https://doi.org/10.1155/jimr/2554167

Vancouver

Zhang L, Chen M, Zhong H, Huang J, Xu Z, Yin M, et al. Detection of Monocyte Subsets in the Bone Marrow of Patients With Acute Myeloid Leukemia and Its Clinical Significance. Journal of Immunology Research. 2025. doi:10.1155/jimr/2554167

BibTeX
@article{Zhang2025,
  author = {Zhang, Liangjun and Chen, Man and Zhong, Huixiu and Huang, Jingyuan and Xu, Ziling and Yin, Minggang and Li, Yi and Cao, Chengjian},
  title = {Detection of Monocyte Subsets in the Bone Marrow of Patients With Acute Myeloid Leukemia and Its Clinical Significance},
  journal = {Journal of Immunology Research},
  year = {2025},
  doi = {10.1155/jimr/2554167}
}
Kostenlos starten →